Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-06

Clinical Trial Update: LALAK for Opacities [NA]

View source ↗

Summary

A clinical trial evaluating LALAK for stromal opacities has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LALAK

Snippet

Sponsor: Oregon Health and Science University | Conditions: STROMAL OPACITIES | NA | Status: WITHDRAWN